Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Merck NYSE:MRK |
294,04 B | 7,67% | 6/6 | -21,36% | -9,57% | 10,99% | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.058,66 B | 20,54% | 5/6 | -8,58% | 68,09% | 26,23% | DOWN |
|
Pfizer NYSE:PFE |
156,83 B | 7,82% | 4/6 | -5,31% | 21,90% | -2,07% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,34 B | 1,77% | 5/6 | -0,30% | -0,63% | 7,69% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
115,27 B | 13,44% | 6/6 | 6,43% | -0,47% | 22,98% | UP |
|
Sanofi ENXTPA:SAN |
96,68 B | 5,21% | 5/6 | 7,19% | 14,18% | 24,91% | DOWN |
|
Takeda Pharmaceutical Company TSE:4502 |
9.145,54 B | 10,31% | 3/5 | 22,10% | -29,78% | 0,19% | UP |
|
Incyte NasdaqGS:INCY |
18,36 B | 41,79% | 5/6 | 8,74% | 31,17% | 15,43% | UP |
|
Ionis Pharmaceuticals NasdaqGS:IONS |
12,26 B | 2,79% | 2/6 | -10,93% | -176,62% | 34,70% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,41 B | 12,22% | 5/6 | 45,50% | 60,07% | 73,62% | DOWN |
|
PTC Therapeutics NasdaqGS:PTCT |
5,55 B | 31,02% | 5/6 | -43,33% | -65,30% | 28,36% | UP |
|
CRISPR Therapeutics NasdaqGM:CRSP |
4,56 B | 30,82% | 2/6 | 1267,38% | 54,84% | 68,24% | DOWN |
|
Disc Medicine NasdaqGM:IRON |
2,37 B | 0,00% | 1/3 | 0,00% | 0,00% | 61,26% | DOWN |
|
Agios Pharmaceuticals NasdaqGS:AGIO |
1,76 B | -20,51% | 2/6 | 69,17% | -37,55% | 23,54% | DOWN |
|
ANI Pharmaceuticals NasdaqGM:ANIP |
1,55 B | 18,85% | 5/6 | 14,66% | 20,70% | 52,41% | DOWN |
|
Geron NasdaqGS:GERN |
0,99 B | 225,94% | 3/5 | 18,44% | 99,22% | 159,74% | DOWN |
|
Teladoc Health NYSE:TDOC |
0,99 B | 15,25% | 5/6 | -0,72% | 75,56% | 8,70% | DOWN |
|
Fulcrum Therapeutics NasdaqGM:FULC |
0,46 B | 0,00% | 1/4 | 0,00% | 0,00% | 209,80% | DOWN |
|
Silence Therapeutics NasdaqGM:SLN |
0,25 B | 46,48% | 2/6 | -87,89% | 63,53% | 370,81% | DOWN |
|
American Well NYSE:AMWL |
0,09 B | 99,43% | 3/4 | -19,95% | 77,57% | -0,18% | DOWN |
